Kun Song

19PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsSocial determinants of health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (19)

|Jul 31, 2026
The prognostic value of surgery in patients with locally advanced vulvar cancer: results from the SEER database and a Chinese multicenter registry.

|Apr 23, 2026
Correction: The splicing factor WBP11 mediates MCM7 intron retention to promote the malignant progression of ovarian cancer.

|Mar 14, 2026
Cadonilimab plus chemotherapy with or without bevacizumab as first-line treatment for advanced cervical cancer: subgroup analyses from the COMPASSION-16 phase 3 trial.

Yang Sun, Hongying Yang, Jing Wang

|Dec 21, 2025
Fruquintinib plus sintilimab in patients with advanced endometrial cancer with mismatch-repair proficient status: a multicenter, single-arm, phase Ib/II trial.

Xiaohua Wu, Jing Wang, Danbo Wang

|Jun 24, 2025
Spliceosomal GTPase EFTUD2 mediates DDX41 intron retention to promote the malignant progression of ovarian cancer.

Yanling Liu, Zhongshao Chen, Yan Duan

|Mar 03, 2025
Global landscape of cervical cancer incidence and mortality in 2022 and predictions to 2030: The urgent need to address inequalities in cervical cancer.

Zhuang Li, Penglin Liu, Aijun Yin

Pageof 4

Frequent Collaborators

4 joint publications

Yingwei Li

3 joint publications

Ran Chu

3 joint publications

Zhongshao Chen

3 joint publications

Beihua Kong